Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Host gene expression profiling of cervical smear is eligible for cancer risk evaluation.

Journal of clinical pathology - 1 Apr 2013

Bourmenskaya Olga, Shubina Ekaterina, Trofimov Dmitry, Rebrikov Denis, Sabdulaeva Elina, Nepsha Oksana, Bozhenko Vladimir, Rogovskaya Svetlana, Sukhikh Gennady

Abstract excerpt

AIMS: Uterine cervical carcinoma (CC) is known to be a delayed consequence of human papillomavirus (HPV) infection. Considering the reported influence of HPV on host genome activity, we conceived an approach to capture human gene expression profiles corresponding to increased risks of carcinogenesis. METHODS: A sample set of 143 female participants included a 'control' group of 23, a 'pathology' group of 83...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chi-Square Distribution
Share to Neoplasm Grading

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Papillomaviridae

Share to Papillomavirus E7 Proteins

Share to Papillomavirus Infections

Share to Uterine Cervical Dysplasia

Share to Uterine Neoplasms

Share to Viral Load

Source

Identifiers

PMID: 23268324
DOI: 10.1136/jclinpath-2012-201313

Genes

MKI67
BAX
CCNB1
PGR
PTEN
PTGS2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Host gene expression profiling of cervical smear is eligible for cancer risk evaluation.PMID 23268324Read ↗

In silico pathway analysis in cervical carcinoma reveals potential new targets for treatmentSemantic proximity Read ↗

Discovery of candidate gene expression signatures in peripheral blood for the screening of cervical cancer.Semantic proximity Read ↗

c-myc copy number gain is a powerful prognosticator of disease outcome in cervical dysplasia.Semantic proximity Read ↗

Gene Expression Changes in Progression of Cervical Neoplasia Revealed by Microarray Analysis of Cervical Neoplastic KeratinocytesSemantic proximity Read ↗

High incidence of triple negative breast cancers following pregnancy and an associated gene expression signatureSemantic proximity Read ↗

Ezrin and E-cadherin expression profile in cervical cytology: a prognostic marker for tumor progression in cervical cancer.Semantic proximity Read ↗

[Genetic and epigenetic factors of cervical tumor progression].Semantic proximity Read ↗

Host genetic polymorphism analysis in cervical cancer.Semantic proximity Read ↗

Correlation of p16INK4A expression and HPV copy number with cellular FTIR spectroscopic signatures of cervical cancer cellsSemantic proximity Read ↗

E7HPV16 Oncogene and 17beta‐Estradiol Stress, Promotes Oncogenic microRNA Expression Patterns, Cell Proliferation and Cervical Intraepithelial Neoplasia 1Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.